Upper Gastrointestinal Bleeding May Unmask Didanosine-Associated Portal Hepatopathy in HIV/HCV Co-infected Patients

被引：11

作者：

Vispo, Eugenia ^{[1
]}

Maida, Ivana ^{[1
]}

Barreiro, Pablo ^{[1
]}

Moreno, Victoria ^{[1
]}

Soriano, Vincent ^{[1
]}

机构：

[1] Hosp Carlos III, Dept Infect Dis, Madrid 28029, Spain

来源：

HIV CLINICAL TRIALS | 2008年 / 9卷 / 06期

关键词：

didanosine; hepatitis C; HIV; portal hypertension;

D O I：

10.1310/hct0906-440

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Three HIV individuals with chronic hepatitis C presented with esophageal variceal bleeding. They had mild liver fibrosis and normal liver function tests. All had received didanosine for long periods. Noncirrhotic portal hypertension associated with didanosine may appear in HIV patients without any liver disease or added to chronic hepatitis C.

引用

页码：440 / 444

页数：5

共 50 条

[21] A Simple and Rapid Method for the Detection of HIV-1/HCV in Co-Infected Patients
Paryan, Mahdi
Moghadam, Mahdi Forouzandeh
Kia, Vahid
Mohammadi-Yeganeh, Samira
Raz, Abbasali
Samiee, Siamak Mirab
IRANIAN JOURNAL OF BIOTECHNOLOGY, 2013, 11 (02) : 74 - 79
[22] Microbial translocation is correlated with HIV evolution in HIV-HCV co-infected patients
Tudesq, Jean-Jacques
Dunyach-Remy, Catherine
Combescure, Christophe
Doncesco, Regine
Laureillard, Didier
Lavigne, Jean-Philippe
Sotto, Albert
PLOS ONE, 2017, 12 (09):
[23] HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes
Garbuglia, Anna Rosa
Monachetti, Alessia
Galli, Claudio
Sabatini, Rosella
Ferreri, Monica Lucia
Capobianchi, Maria Rosaria
Bagnarelli, Patrizia
BMC INFECTIOUS DISEASES, 2014, 14
[24] Modulation of HCV replication after combination antiretroviral therapy in HCV/HIV co-infected patients
Sherman, Kenneth E.
Guedj, Jeremie
Shata, Mohamed Tarek
Blackard, Jason T.
Rouster, Susan D.
Castro, Mario
Feinberg, Judith
Sterling, Richard K.
Goodman, Zachary
Aronow, Bruce J.
Perelson, Alan S.
SCIENCE TRANSLATIONAL MEDICINE, 2014, 6 (246)
[25] Hepatitis C Direct-Acting Antiviral Agents in HIV/HCV Co-infected Patients
Valérie Martel-Laferrière
Douglas T. Dieterich
Current Treatment Options in Infectious Diseases, 2014, 6 (2) : 132 - 143
[26] HCV Genotype Distribution and Clinical Characteristics of HCV Mono-Infected and HCV/HIV Co-Infected Patients in Liangshan Prefecture, Sichuan Province, China
Cao, Bianchuan
Liu, Mei
Jiang, Tao
Yu, Qinghua
Yuan, Tianru
Ding, Ping
Zhou, Xian
Huang, Yongmao
Zou, Yongsheng
Huang, Fuli
JOURNAL OF THE INTERNATIONAL ASSOCIATION OF PROVIDERS OF AIDS CARE, 2023, 22
[27] HIV-HCV co-infected patients with low CD4+cell nadirs are at risk for faster fibrosis progression and portal hypertension
Reiberger, T.
Ferlitsch, A.
Sieghart, W.
Kreil, A.
Breitenecker, F.
Rieger, A.
Schmied, B.
Gangl, A.
Peck-Radosavljevic, M.
JOURNAL OF VIRAL HEPATITIS, 2010, 17 (06) : 400 - 409
[28] Impact of antiretroviral therapy on the variability of the HCV NS5B polymerase in HIV/HCV co-infected patients
Plaza, Zulema
Soriano, Vincent
del Mar Gonzalez, Maria
Di Lello, Federico A.
Macias, Juan
Labarga, Pablo
Antonio Pineda, Juan
Poveda, Eva
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2011, 66 (12) : 2838 - 2842
[29] Intrahepatic HCV RNA loads in 37 HIV-HCV co-infected patients with controlled HIV infection
Trimoulet, P
Neau, D
Le Bail, B
Rullier, A
Winnock, M
Galperine, T
Legrand, E
Schvoerer, E
Dupon, M
Ragnaud, JM
Bioulac-Sage, P
Chêne, G
Fleury, H
Lafon, ME
JOURNAL OF MEDICAL VIROLOGY, 2002, 67 (02) : 143 - 151
[30] Contemporary HCV pangenotypic DAA treatment protocols are exclusionary to real world HIV-HCV co-infected patients
Maughan, A.
Sadigh, K.
Angulo-Diaz, V.
Mandimika, C.
Villanueva, M.
Lim, J. K.
Ogbuagu, O.
BMC INFECTIOUS DISEASES, 2019, 19 (1)

← 1 2 3 4 5 →